Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Insperity, Inc. (“Insperity” or “the Company”) (NYSE: NSP). Investors who purchased Insperity securities are encouraged to obtain additional information and assist the investigation.

The investigation concerns whether Insperity has violated federal securities laws.

Investigation Details

On August 1, 2025, Insperity released its Q2 2025 financial results. The Company’s earnings per share fell 70% year-over-year, missing analyst expectations. The Company blamed its performance on pharmacy expenses, high benefit costs, and large insurance claims. The company also revised its full-year earnings guidance downward. Following this news, Insperity’s stock dropped more than 24% on the same day.

What’s Next?

If you are aware of any facts relating to this investigation or purchased Insperity securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660